
Heska Corporation HSKA
Quarterly report 2023-Q1
added 05-05-2023
Heska Corporation P/S Ratio 2011-2025 | HSKA
Annual P/S Ratio Heska Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.28 | 7.2 | 6.39 | 6.19 | 5.58 | 4.27 | 4.18 | 2.32 | 1.32 | 0.635 | 0.615 | 0.567 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7.2 | 0.567 | 3.55 |
P/S Ratio of other stocks in the Diagnostics research industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
1.72 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
0.1 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
13.5 | - | -61.36 % | $ 2.46 M | ||
|
Brainsway Ltd.
BWAY
|
8.09 | $ 18.68 | -3.56 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
6.87 | $ 20.72 | -3.9 % | $ 223 M | ||
|
Co-Diagnostics
CODX
|
5.13 | $ 0.23 | -2.72 % | $ 6.75 M | ||
|
Biocept
BIOC
|
0.229 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
0.254 | - | 0.22 % | $ 16.8 M | ||
|
Castle Biosciences
CSTL
|
2.14 | $ 39.21 | -0.47 % | $ 1.09 B | ||
|
Danaher Corporation
DHR
|
6.37 | $ 230.38 | 0.02 % | $ 168 B | ||
|
DarioHealth Corp.
DRIO
|
2.13 | $ 10.32 | 2.79 % | $ 293 M | ||
|
BioNano Genomics
BNGO
|
0.115 | $ 1.5 | -1.11 % | $ 1.91 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
5.71 | - | - | $ 562 M | ||
|
Exact Sciences Corporation
EXAS
|
3.38 | $ 101.55 | -0.02 % | $ 18.8 B | ||
|
DexCom
DXCM
|
13.5 | $ 67.58 | 0.01 % | $ 26.1 B | ||
|
Enzo Biochem
ENZ
|
0.0018 | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
1.65 | $ 26.45 | -1.01 % | $ 800 M | ||
|
Global Cord Blood Corporation
CO
|
0.196 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
3.48 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
1.36 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
2.9 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
2.77 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
2.47 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
1.86 | $ 18.97 | -2.62 % | $ 1.02 B | ||
|
Anixa Biosciences
ANIX
|
0.337 | $ 3.18 | -0.62 % | $ 101 K | ||
|
HTG Molecular Diagnostics
HTGM
|
0.469 | - | -20.0 % | $ 1.06 M | ||
|
IQVIA Holdings
IQV
|
2.31 | $ 226.1 | -0.36 % | $ 41 B | ||
|
Guardant Health
GH
|
7.91 | $ 101.78 | -1.17 % | $ 12.5 B | ||
|
Aspira Women's Health
AWH
|
5.55 | - | -6.19 % | $ 10.5 M | ||
|
Myriad Genetics
MYGN
|
1.16 | $ 6.35 | -2.01 % | $ 575 M | ||
|
ENDRA Life Sciences
NDRA
|
1.59 K | $ 4.95 | -0.85 % | $ 2.66 M | ||
|
Neogen Corporation
NEOG
|
1.14 | $ 7.19 | 0.84 % | $ 1.56 B | ||
|
National Research Corporation
NRC
|
6.79 | $ 18.72 | 0.32 % | $ 459 M | ||
|
Illumina
ILMN
|
3.75 | $ 133.49 | -1.09 % | $ 21.2 B | ||
|
Charles River Laboratories International
CRL
|
2.11 | $ 202.84 | -0.35 % | $ 10.4 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.93 | $ 174.86 | -0.63 % | $ 19.4 B | ||
|
Biodesix
BDSX
|
1.29 | $ 6.77 | -0.73 % | $ 878 M | ||
|
Koninklijke Philips N.V.
PHG
|
1.8 | $ 27.19 | 0.3 % | $ 20 B | ||
|
Motus GI Holdings
MOTS
|
3.1 | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
1.62 | $ 252.44 | -0.6 % | $ 21.2 B | ||
|
ICON Public Limited Company
ICLR
|
3.25 | $ 182.31 | -0.29 % | $ 15 B | ||
|
IDEXX Laboratories
IDXX
|
9.66 | $ 682.03 | -0.94 % | $ 56.2 B | ||
|
Personalis
PSNL
|
3 | $ 8.04 | -1.23 % | $ 476 M | ||
|
Lantheus Holdings
LNTH
|
4.21 | $ 66.81 | 0.15 % | $ 4.62 B | ||
|
Mettler-Toledo International
MTD
|
7.72 | $ 1 411.55 | -0.62 % | $ 30 B | ||
|
Quidel Corporation
QDEL
|
6.36 | $ 29.19 | -0.38 % | $ 1.23 B | ||
|
Agilent Technologies
A
|
6.64 | $ 137.82 | -0.41 % | $ 41.9 B | ||
|
RadNet
RDNT
|
2.01 | $ 72.76 | -0.53 % | $ 5.31 B |